Want to join the conversation?
$KLAC's 2Q16 cost of revenues were $281MM, which compared to $283.2MM in 2Q15. Engineering, research and development expenses in 2Q16 were $118.8MM compared to $133.6MM in the corresponding period last year. Selling, general and administrative expenses were $96.5MM versus $104.9MM in 2Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?